Combining synthetic biology and artificial intelligence to make cancer detection as easy as a pregnancy test.
Cleancard is a pioneering biotechnology company focused on revolutionizing early cancer detection through innovative diagnostic solutions. Cleancard is dedicated to bringing lab-grade diagnostics into the comfort of your home, making health monitoring more accessible and convenient than ever before. With a commitment to innovation, Cleancard is transforming the landscape of personalized healthcare.
Located in San Francisco, US, Cleancard is developing cutting-edge methods for robust diagnostics and biomarker tracking from urine samples, delivering results in just 30 minutes. The company’s rapid at-home screens are designed to identify prostate, bladder, and ovarian cancers, offering a proactive approach to health management. Cleancard is continually expanding its platform technology to detect a wider range of conditions from a single sample, ensuring comprehensive and timely health insights.
Cleancard is committed to advancing healthcare through accessible and reliable diagnostic solutions. The company's focus on combining synthetic biology and artificial intelligence positions Cleancard as a leader in the biotechnology industry. We invite the management team at Cleancard to take the next step and create a customized and exclusive company showcase and product listing on our platform, further enhancing their market presence and commercial opportunities.
Other organizations in the same industry
This company is also known as